ArticleCell research2015

Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25.

Dalil Hannani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.